Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is N/A as of Tuesday, October 6, 2026.
INTEREST COVERAGE RATIO
N/A
Obsidian Therapeutics Inc.
Market Cap
$14.17M
Interest Coverage Ratio
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO |
|---|---|---|
| Obsidian Therapeutics Inc. (OBX) | $14.17M | N/A |
| Sintx Technologies, Inc. (SINT)vs › | $13.92M | -206.17x |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.78M | -143.87x |
| Vyome Holdings, Inc. (HIND)vs › | $13.66M | -18.73x |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.31M | -38.62x |
| IN8bio, Inc. (INAB)vs › | $13.71M | N/A |
| Optimi Health Corp. (OPTH)vs › | $13.51M | -8.52x |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.98M | N/A |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.78M | N/A |
| Passage Bio, Inc. (PASG)vs › | $13.24M | N/A |
Interest Coverage
N/A
Debt/Equity
N/A
Current Ratio
N/A
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
